menu search

PSYBF / PsyBio Therapeutics successfully demonstrates commercial-scale manufacturing feasibility

PsyBio Therapeutics successfully demonstrates commercial-scale manufacturing feasibility
PsyBio Therapeutics Corp. reported that it has demonstrated the ability to manufacture PsyBio-11040, one of its first promising therapeutic candidates, at a commercial scale.  The company said this is the result of numerous dedicated employees, consultants and contractors committing thousands of hours and almost a year of efforts that have taken the technology, exclusively licensed to PsyBio, from bench scale to commercial scale. Read More
Posted: Oct 7 2021, 09:12
Author Name: Proactive Investors
Views: 102785

PSYBF News  

PsyBio Therapeutics successfully demonstrates commercial-scale manufacturing feasibility

By Proactive Investors
October 7, 2021

PsyBio Therapeutics successfully demonstrates commercial-scale manufacturing feasibility

PsyBio Therapeutics Corp. reported that it has demonstrated the ability to manufacture PsyBio-11040, one of its first promising therapeutic candidates more_horizontal

PsyBio Therapeutics successfully demonstrates commercial-scale manufacturing feasibility

By Proactive Investors
October 7, 2021

PsyBio Therapeutics successfully demonstrates commercial-scale manufacturing feasibility

PsyBio Therapeutics Corp. reported that it has demonstrated the ability to manufacture PsyBio-11040, one of its first promising therapeutic candidates more_horizontal

PsyBio Therapeutics successfully demonstrates commercial-scale manufacturing feasibility

By Proactive Investors
October 7, 2021

PsyBio Therapeutics successfully demonstrates commercial-scale manufacturing feasibility

PsyBio Therapeutics Corp. reported that it has demonstrated the ability to manufacture PsyBio-11040, one of its first promising therapeutic candidates more_horizontal


Search within

Pages Search Results: